| Financial Year |
March 31 2023 |
| Monetary Funds |
266,796,511.46 |
| Held-for-trading Financial Assets |
174,442,223.40 |
| Notes Receivable |
25,777,753.81 |
| Accounts Receivable |
1,201,600,107.58 |
| Advances to Suppliers |
80,361,583.68 |
| Other Receivables |
53,931,326.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
131,470,089.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
30,651.99 |
| Other Current Assets |
15,971,934.35 |
| Total Current Assets |
2,048,251,365.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
107,067.41 |
| Long-term Equity Investment |
694,744.36 |
| Investment Properties |
64,365,716.40 |
| Fixed Assetes |
111,821,848.19 |
| Under-construction Projects |
1,092,660.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
508,293,252.81 |
| R&D expenses |
352,753,185.35 |
| Goodwill |
101,750,907.74 |
| Long-Term Deferred and Prepaid Expenses |
20,513,722.09 |
| Deferred Income Tax Assets |
25,357,061.76 |
| Other Non-Current Assets |
18,972,022.30 |
| Sub-Total of Non-Current Assets |
1,229,572,459.55 |
| Total Assets |
3,277,823,824.81 |
| Short-Term Loans |
75,931,182.77 |
| Trading Financial liabilities |
-- |
| Notes Payable |
43,534,141.00 |
| Accounts Payable |
331,352,455.53 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,257,423.57 |
| Taxes Payable |
30,594,027.03 |
| Interest Payable |
-- |
| Dividend Payable |
36,000,000.00 |
| Other payables |
46,831,960.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,230,702.92 |
| Other Current Liabilities |
14,580,172.18 |
| Sub-Total of Current Liabilities |
678,775,961.53 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,468,504.06 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
31,292,701.18 |
| Total Liabilities |
710,068,662.71 |
| Paid-In Capital(Or Share Stock) |
166,568,333.00 |
| Capital Surplus |
1,517,595,772.22 |
| Surplus Reserve |
46,573,213.61 |
| LESS:Treasury Stock |
47,000,692.88 |
| Undistributed Profits |
845,372,363.85 |
| Minority Stockholder's Interest |
38,646,172.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,529,108,989.80 |
| Owner's Equity（Stockholder's Equity） |
2,567,755,162.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,277,823,824.81 |
